The Journal of Viral Hepatitis publishes a variety of articles across the specialty of viral hepatitis, soliciting research from epidemiologists, clinicians, pathologists, virologists and specialists in …

2023年1月24日 · The immune landscape in hepatitis delta virus infection—Still an open field! Olga V. Isaeva, Karen K. Kyuregyan, Anastasia A. Karlsen, Oleg V. Kuzmin, Ilya A. Potemkin, Vera …

Beclabuvir (also known by the research name BMS-791325; abbreviated BCV) is an antiviral drug for the treatment of hepatitis C virus (HCV) infection that has been studied in clinical trials.

We aimed to investigate the proportion of chronic HBV infection patients in the grey zone, and evaluate the clinical characteristics and liver pathological changes in grey zone patients. …

Journal of Viral Hepatitis published by John Wiley & Sons Ltd. Vaccination and anti-viral therapy with nucleos (t)ide analogues (NAs) are key approaches to reducing the morbidity, mortality …

2 天之前 · JOURNAL OF VIRAL HEPATITIS杂志网站提供J VIRAL HEPATITIS期刊影响因子、JCR和中科院分区查询，SCI期刊投稿经验，Impact Factor（IF），官方投稿网址，审稿周期/ …

2022年1月18日 · 《JOURNAL OF VIRAL HEPATITIS》主要发表病毒性肝炎的相关文章。 涉及领域包括有：病毒性肝炎、抗病毒药物、细胞因子、诊断技术、遗传、遗传学、肝炎、肝病、免 …

DOI: 10.1111/jvh.13926 Abstract There are estimated 300 million people afflicted with chronic hepatitis B (CHB) worldwide. The risk of liver cirrhosis and hepatocellular carcinoma (HCC) …

The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis.

2024年12月27日 · Patients with HBsAg > 250 IU/mL (p < 0.001) and high anti-HBc (p = 0.001) had lower cumulative HBsAg clearance rates than those with low HBsAg and anti-HBc. 11.1% …